硝唑尼特的 2-氨基-5-硝基噻唑酰胺类似物的修饰和交换的生物活性。
Biological activity of modified and exchanged 2-amino-5-nitrothiazole amide analogues of nitazoxanide.
机构信息
Department of Chemistry, University of Virginia, Charlottesville, VA 22904-4319, USA.
出版信息
Bioorg Med Chem Lett. 2010 Jun 15;20(12):3537-9. doi: 10.1016/j.bmcl.2010.04.126. Epub 2010 May 18.
Abstract
Head group analogues of the antibacterial and antiparasitic drug nitazoxanide (NTZ) are presented. A library of 39 analogues was synthesized and assayed for their ability to suppress growth of Helicobacter pylori, Campylobacter jejuni, Clostridium difficile and inhibit NTZ target pyruvate:ferredoxin oxidoreductase (PFOR). Two head groups assayed recapitulated NTZ activity and possessed improved activity over their 2-amino-5-nitrothiazole counterparts, demonstrating that head group modification is a viable route for the synthesis of NTZ-related antibacterial analogues.
摘要
呈现了抗菌和抗寄生虫药物硝唑尼特（NTZ）的头基类似物。合成了 39 个类似物库，并对它们抑制幽门螺杆菌、空肠弯曲菌、艰难梭菌生长的能力以及抑制 NTZ 靶标丙酮酸：铁氧还蛋白氧化还原酶（PFOR）的能力进行了检测。两种被检测的头基重现了 NTZ 的活性，并且比其 2-氨基-5-硝基噻唑对应物具有更好的活性，这表明对头基的修饰是合成 NTZ 相关抗菌类似物的可行途径。
相似文献
1
Biological activity of modified and exchanged 2-amino-5-nitrothiazole amide analogues of nitazoxanide.硝唑尼特的 2-氨基-5-硝基噻唑酰胺类似物的修饰和交换的生物活性。
Bioorg Med Chem Lett. 2010 Jun 15;20(12):3537-9. doi: 10.1016/j.bmcl.2010.04.126. Epub 2010 May 18.
2
Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model.阿米西利，一种新型丙酮酸：铁氧还蛋白氧化还原酶抑制剂，在艰难梭菌感染小鼠模型中显示出疗效。
Antimicrob Agents Chemother. 2012 Aug;56(8):4103-11. doi: 10.1128/AAC.00360-12. Epub 2012 May 14.
3
Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni.抗寄生虫药物硝唑尼特可抑制幽门螺杆菌、某些厌氧菌和寄生虫以及空肠弯曲菌的丙酮酸氧化还原酶。
Antimicrob Agents Chemother. 2007 Mar;51(3):868-76. doi: 10.1128/AAC.01159-06. Epub 2006 Dec 11.
4
Synthesis and antimicrobial evaluation of nitazoxanide-based analogues: identification of selective and broad spectrum activity.基于硝唑尼特的类似物的合成及抗菌评价：选择性和广谱活性的鉴定。
ChemMedChem. 2011 Feb 7;6(2):362-77. doi: 10.1002/cmdc.201000475. Epub 2010 Dec 29.
5
Synthesis and Antimicrobial Evaluation of Amixicile-Based Inhibitors of the Pyruvate-Ferredoxin Oxidoreductases of Anaerobic Bacteria and Epsilonproteobacteria.基于阿米西克的厌氧菌和ε-变形菌丙酮酸-铁氧还蛋白氧化还原酶抑制剂的合成与抗菌评价
Antimicrob Agents Chemother. 2016 Jun 20;60(7):3980-7. doi: 10.1128/AAC.00670-16. Print 2016 Jul.
6
Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori.阿米西icile的临床前研究，阿米西icile是一种开发用于治疗艰难梭菌感染的全身治疗药物，对幽门螺杆菌也有疗效。
Antimicrob Agents Chemother. 2014 Aug;58(8):4703-12. doi: 10.1128/AAC.03112-14. Epub 2014 Jun 2.
7
In vitro and in vivo activities of nitazoxanide against Clostridium difficile.硝唑尼特对艰难梭菌的体外和体内活性
Antimicrob Agents Chemother. 2000 Sep;44(9):2254-8. doi: 10.1128/AAC.44.9.2254-2258.2000.
8
Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity.硝唑尼特是一种硝基噻唑类抗寄生虫药物，是一种具有抗空泡毒素活性的抗幽门螺杆菌药物。
Chemotherapy. 1999 Jul-Aug;45(4):303-12. doi: 10.1159/000007200.
9
Flavodoxin:quinone reductase (FqrB): a redox partner of pyruvate:ferredoxin oxidoreductase that reversibly couples pyruvate oxidation to NADPH production in Helicobacter pylori and Campylobacter jejuni.黄素氧还蛋白：醌还原酶（FqrB）：丙酮酸：铁氧化还原蛋白氧化还原酶的一种氧化还原伴侣，在幽门螺杆菌和空肠弯曲菌中，它可将丙酮酸氧化与NADPH生成可逆偶联。
J Bacteriol. 2007 Jul;189(13):4764-73. doi: 10.1128/JB.00287-07. Epub 2007 Apr 27.
10
Synthesis, in vitro bioassays, and computational study of heteroaryl nitazoxanide analogs.杂芳基硝唑尼特类似物的合成、体外生物测定和计算研究。
Pharmacol Res Perspect. 2021 May;9(3):e00800. doi: 10.1002/prp2.800.
引用本文的文献
1
New nitazoxanide derivatives: design, synthesis, biological evaluation, and molecular docking studies as antibacterial and antimycobacterial agents.新型硝唑尼特衍生物：作为抗菌和抗分枝杆菌剂的设计、合成、生物学评价及分子对接研究
RSC Med Chem. 2023 Oct 10;14(12):2714-2730. doi: 10.1039/d3md00449j. eCollection 2023 Dec 13.
2
Amidinoquinoxaline -oxides: synthesis and activity against anaerobic bacteria.脒基喹喔啉氧化物：合成及其对厌氧菌的活性
RSC Adv. 2023 Sep 13;13(39):27391-27402. doi: 10.1039/d3ra01184d. eCollection 2023 Sep 8.
3
Nitazoxanide Inhibits the Bifunctional Enzyme GlG6PD::6PGL of : Biochemical and In Silico Characterization of a New Druggable Target.硝唑尼特抑制双功能酶 GlG6PD::6PGL 的作用：一个新的可药物作用靶点的生化和计算特征研究。
Int J Mol Sci. 2023 Jul 15;24(14):11516. doi: 10.3390/ijms241411516.
4
CDBN-YGXZ, a Novel Small-Molecule Drug, Shows Efficacy against Clostridioides difficile Infection and Recurrence in Mouse and Hamster Infection Models.CDBN-YGXZ，一种新型小分子药物，在艰难梭菌感染和复发的小鼠和仓鼠感染模型中显示出疗效。
Antimicrob Agents Chemother. 2023 May 17;67(5):e0170422. doi: 10.1128/aac.01704-22. Epub 2023 Apr 13.
5
Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents.设计并合成了新型硝噻唑乙酰胺与不同硫代喹唑啉酮衍生物的轭合物作为抗脲酶剂。
Sci Rep. 2022 Feb 7;12(1):2003. doi: 10.1038/s41598-022-05736-4.
6
Cationic Peptidomimetic Amphiphiles Having a -Aryl- or -Naphthyl-1,2,3-Triazole Core Structure Targeting () : Synthesis, Antibacterial Evaluation, and an In Vivo Infection Model.具有靶向（）的 - 芳基 - 或 - 萘基 - 1,2,3 - 三唑核心结构的阳离子拟肽两亲物：合成、抗菌评估及体内感染模型
Antibiotics (Basel). 2021 Jul 26;10(8):913. doi: 10.3390/antibiotics10080913.
7
Novel Nitro-Heteroaromatic Antimicrobial Agents for the Control and Eradication of Biofilm-Forming Bacteria.用于控制和根除形成生物膜细菌的新型硝基杂芳族抗菌剂
Antibiotics (Basel). 2021 Jul 14;10(7):855. doi: 10.3390/antibiotics10070855.
8
Synthesis, in vitro bioassays, and computational study of heteroaryl nitazoxanide analogs.杂芳基硝唑尼特类似物的合成、体外生物测定和计算研究。
Pharmacol Res Perspect. 2021 May;9(3):e00800. doi: 10.1002/prp2.800.
9
A small molecule screening to detect potential therapeutic targets in human podocytes.一种用于检测人足细胞中潜在治疗靶点的小分子筛选。
Am J Physiol Renal Physiol. 2017 Jan 1;312(1):F157-F171. doi: 10.1152/ajprenal.00386.2016. Epub 2016 Oct 19.
10
Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds.基于5-硝基-2-氨基噻唑的化合物的抗锥虫活性。
Eur J Med Chem. 2016 Jul 19;117:179-86. doi: 10.1016/j.ejmech.2016.04.010. Epub 2016 Apr 8.
本文引用的文献
1
Nitazoxanide inhibits biofilm formation by Staphylococcus epidermidis by blocking accumulation on surfaces.硝唑尼特通过阻止表皮葡萄球菌在表面上的聚集来抑制生物膜的形成。
Antimicrob Agents Chemother. 2010 Jul;54(7):2767-74. doi: 10.1128/AAC.00901-09. Epub 2010 Apr 19.
2
Nitazoxanide inhibits biofilm production and hemagglutination by enteroaggregative Escherichia coli strains by blocking assembly of AafA fimbriae.硝唑尼特通过阻断 AafA 菌毛的组装来抑制肠聚集性大肠杆菌菌株的生物膜生成和血凝作用。
Antimicrob Agents Chemother. 2010 Apr;54(4):1526-33. doi: 10.1128/AAC.01279-09. Epub 2010 Jan 19.
3
Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes.应用基于磷酸葡萄糖异构酶释放的体外药物筛选测定法来确定噻唑烷类化合物对多房棘球蚴原头蚴的构效关系。
J Antimicrob Chemother. 2010 Mar;65(3):512-9. doi: 10.1093/jac/dkp490. Epub 2010 Jan 19.
4
Evaluation of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum.评价新型噻唑烷/噻二唑烷衍生物对隐孢子虫体外发育的疗效，发现与硝基基团无关。
Antimicrob Agents Chemother. 2010 Mar;54(3):1315-8. doi: 10.1128/AAC.00614-09. Epub 2010 Jan 4.
5
Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance.硝唑尼特可杀死正在复制和非复制状态的结核分枝杆菌，并能避免耐药性产生。
J Med Chem. 2009 Oct 8;52(19):5789-92. doi: 10.1021/jm9010719.
6
Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level.噻唑类化合物，一类新型的抗流感分子，在翻译后水平靶向病毒血凝素。
J Biol Chem. 2009 Oct 23;284(43):29798-808. doi: 10.1074/jbc.M109.029470. Epub 2009 Jul 28.
7
Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori.幽门螺杆菌RdxA硝基还原酶的NAD(P)H氧化酶和甲硝唑还原酶活性的表征
FEBS J. 2009 Jun;276(12):3354-64. doi: 10.1111/j.1742-4658.2009.07060.x. Epub 2009 May 7.
8
Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.硝唑尼特、聚乙二醇干扰素和利巴韦林治疗慢性丙型肝炎基因4型的病毒学应答改善。
Gastroenterology. 2009 Mar;136(3):856-62. doi: 10.1053/j.gastro.2008.11.037. Epub 2008 Nov 19.
9
Clostridium difficile--more difficult than ever.艰难梭菌——比以往任何时候都更难对付。
N Engl J Med. 2008 Oct 30;359(18):1932-40. doi: 10.1056/NEJMra0707500.
10
Nitazoxanide: a review of its use in the treatment of gastrointestinal infections.硝唑尼特：用于治疗胃肠道感染的综述
Drugs. 2007;67(13):1947-67. doi: 10.2165/00003495-200767130-00015.
Zotero 插件